menu
    • menu
    [{"orgOrder":0,"company":"DISCO Pharmaceuticals","sponsor":"Sofinnova Partners","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"GERMANY","productType":"Undisclosed","year":"2024","type":"Financing","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Oncology","graph2":"Preclinical","graph3":"DISCO Pharmaceuticals","amount2":0.02,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Oncology","amount2New":0.02,"dosageForm":"Undisclosed","sponsorNew":"DISCO Pharmaceuticals \/ Sofinnova Partners","highestDevelopmentStatusID":"4","companyTruncated":"DISCO Pharmaceuticals \/ Sofinnova Partners"},{"orgOrder":0,"company":"DISCO Pharmaceuticals","sponsor":"Ackermans & van Haaren | NRW.Bank | Sofinnova Partners | AbbVie Ventures | M Ventures | Panakes Partners","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"GERMANY","productType":"Antibody-drug Conjugate","year":"2025","type":"Financing","leadProduct":"Undisclosed","moa":"Surfaceome","graph1":"Oncology","graph2":"Preclinical","graph3":"DISCO Pharmaceuticals","amount2":0.040000000000000001,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Oncology","amount2New":0.040000000000000001,"dosageForm":"Undisclosed","sponsorNew":"DISCO Pharmaceuticals \/ Ackermans & van Haaren | NRW.Bank | Sofinnova Partners | AbbVie Ventures | M Ventures | Panakes Partners","highestDevelopmentStatusID":"4","companyTruncated":"DISCO Pharmaceuticals \/ Ackermans & van Haaren | NRW.Bank | Sofinnova Partners | AbbVie Ventures | M Ventures | Panakes Partners"},{"orgOrder":0,"company":"DISCO Pharmaceuticals","sponsor":"Amgen Inc","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"GERMANY","productType":"Antibody, Unconjugated","year":"2026","type":"Licensing Agreement","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Oncology","graph2":"Preclinical","graph3":"DISCO Pharmaceuticals","amount2":0.62,"highestDevelopmentShortName":"Preclinical","therapeuticAreaShortName":"Oncology","amount2New":0.62,"dosageForm":"Undisclosed","sponsorNew":"DISCO Pharmaceuticals \/ Amgen Inc","highestDevelopmentStatusID":"4","companyTruncated":"DISCO Pharmaceuticals \/ Amgen Inc"}]

    Find Clinical Drug Pipeline Developments & Deals by DISCO Pharmaceuticals

    Menu

    DISCO Pharmaceuticals

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            DISCO Pharmaceuticals

                            Germany arrow
                            VMX
                            Not Confirmed

                            DISCO Pharmaceuticals

                            Germany arrow
                            VMX
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Oncology

                            Study Phase : Preclinical

                            Sponsor : Amgen Inc

                            Deal Size : $618.0 million

                            Deal Type : Licensing Agreement

                            DEALS_DEV arrow-down

                            Disco Pharmaceuticals Licenses Novel Cancer Surfaceome Targeted Therapies

                            Details : Through the licensing deal, an undisclosed antibody for Small Cell Lung Cancer will be developed, addressing a key focus area in SCLC research.

                            Product Name : Undisclosed

                            Product Type : Antibody, Unconjugated

                            Upfront Cash : Undisclosed

                            January 07, 2026

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Oncology

                            Highest Development Status : Preclinical

                            Sponsor : Amgen Inc

                            Deal Size : $618.0 million

                            Deal Type : Licensing Agreement

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            DISCO Pharmaceuticals

                            Germany arrow
                            VMX
                            Not Confirmed

                            DISCO Pharmaceuticals

                            Germany arrow
                            VMX
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Oncology

                            Study Phase : Preclinical

                            Sponsor : Ackermans & van Haaren | NRW.Bank | Sofinnova Partners | AbbVie Ventures | M Ventures | Panakes Partners

                            Deal Size : $42.1 million

                            Deal Type : Financing

                            DEALS_DEV arrow-down

                            Disco Pharmaceuticals Names Mark Manfredi CEO, Closes €36M Seed Financing

                            Details : The financing will support the development of an undisclosed antibody-drug conjugate targeting the Surfaceome in Small Cell Lung Cancer.

                            Product Name : Undisclosed

                            Product Type : Antibody-drug Conjugate

                            Upfront Cash : Undisclosed

                            December 11, 2025

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Oncology

                            Highest Development Status : Preclinical

                            Sponsor : Ackermans & van Haaren | NRW.Bank | Sofinnova Partners | AbbVie Ventures | M Ventures | Panakes Partners

                            Deal Size : $42.1 million

                            Deal Type : Financing

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            DISCO Pharmaceuticals

                            Germany arrow
                            VMX
                            Not Confirmed

                            DISCO Pharmaceuticals

                            Germany arrow
                            VMX
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Oncology

                            Study Phase : Discovery Platform

                            Sponsor : Sofinnova Partners

                            Deal Size : $21.7 million

                            Deal Type : Financing

                            DEALS_DEV arrow-down

                            DISCO Pharmaceuticals Launches as Surfaceome Company with EUR 20 Million in Seed Funding

                            Details : The net proceeds will be used for the development of new treatment modalities such as antibody-drug conjugates (ADCs) and bi-specific antibodies, in oncology.

                            Product Name : Undisclosed

                            Product Type : Undisclosed

                            Upfront Cash : Undisclosed

                            January 16, 2024

                            Lead Product(s) : Undisclosed

                            Therapeutic Area : Oncology

                            Highest Development Status : Discovery Platform

                            Sponsor : Sofinnova Partners

                            Deal Size : $21.7 million

                            Deal Type : Financing

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            • Privacy policy
                            • Terms and conditions
                            • Disclaimers
                            • LinkedIn
                            • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.